Heterogenous biochemical expression of hormone activity in subclinical/overt hyperthyroidism and exogenous thyrotoxicosis

Background: Subclinical hyperthyroidism/thyrotoxicosis originates from different causes and clinical conditions, sharing the laboratory constellation of a suppressed TSH in the presence of thyroid hormone concentrations within the reference range. Aim: Presentation of hyperthyroidism can manifest it...

Full description

Bibliographic Details
Main Authors: Rudolf Hoermann, John E.M. Midgley, Rolf Larisch, Johannes W. Dietrich
Format: Article
Language:English
Published: Elsevier 2020-03-01
Series:Journal of Clinical & Translational Endocrinology
Online Access:http://www.sciencedirect.com/science/article/pii/S2214623719301528
_version_ 1819020031524077568
author Rudolf Hoermann
John E.M. Midgley
Rolf Larisch
Johannes W. Dietrich
author_facet Rudolf Hoermann
John E.M. Midgley
Rolf Larisch
Johannes W. Dietrich
author_sort Rudolf Hoermann
collection DOAJ
description Background: Subclinical hyperthyroidism/thyrotoxicosis originates from different causes and clinical conditions, sharing the laboratory constellation of a suppressed TSH in the presence of thyroid hormone concentrations within the reference range. Aim: Presentation of hyperthyroidism can manifest itself in several ways. We questioned whether there is either a consistent biochemical equivalence of thyroid hormone response to these diagnostic categories, or a high degree of heterogeneity may exist both within and between the different clinical manifestations. Methods: This secondary analysis of a former prospective cross-sectional trial involved 461 patients with untreated thyroid autonomy, Graves’ disease or on levothyroxine (LT4) after thyroidectomy for thyroid carcinoma. TSH response and biochemical equilibria between TSH and thyroid hormones were contrasted between endogenous hyperthyroidism and thyrotoxicosis (LT4 overdose). Results: Concentrations of FT4, FT3, TSH, deiodinase activity and BMI differed by diagnostic category. Over various TSH strata, FT4 concentrations were significantly higher in LT4-treated thyroid carcinoma patients, compared to the untreated diseases, though FT3 levels remained comparable. They were concentrated in the upper FT4- but low deiodinase range, distinguishing them from patients with thyroid autonomy and Graves’ disease. In exogenous thyrotoxicosis, TSH and FT3 were less responsive to FT4 concentrations approaching its upper normal/hyperthyroid range. Conclusions: The presence or lack of TSH feedforward activity determines the system response in the thyroid-active (hyperthyroidism) and no-thyroid response to treatment (thyrotoxicosis). This rules out a consistent thread of thyroid hormone response running through the different diagnostic categories. TSH measurements should therefore be interpreted conditionally and differently in subclinical hyperthyroidism and thyrotoxicosis. Keywords: Subclinical hyperthyroidism, Thyrotoxicosis, Deiodinase
first_indexed 2024-12-21T03:44:45Z
format Article
id doaj.art-f3ac61de449a4a7aa604e85ca7f04325
institution Directory Open Access Journal
issn 2214-6237
language English
last_indexed 2024-12-21T03:44:45Z
publishDate 2020-03-01
publisher Elsevier
record_format Article
series Journal of Clinical & Translational Endocrinology
spelling doaj.art-f3ac61de449a4a7aa604e85ca7f043252022-12-21T19:17:07ZengElsevierJournal of Clinical & Translational Endocrinology2214-62372020-03-0119Heterogenous biochemical expression of hormone activity in subclinical/overt hyperthyroidism and exogenous thyrotoxicosisRudolf Hoermann0John E.M. Midgley1Rolf Larisch2Johannes W. Dietrich3Department for Nuclear Medicine, Klinikum Lüdenscheid, Paulmannshöherstr. 14, 58515 Lüdenscheid, Germany; Corresponding author at: Klinikum Lüdenscheid, Paulmannshöher Str 14, D-58515 Lüdenscheid, Germany.North Lakes Clinical, 20 Wheatley Avenue, Ilkley LS29 8PT, UKDepartment for Nuclear Medicine, Klinikum Lüdenscheid, Paulmannshöherstr. 14, 58515 Lüdenscheid, GermanyMedical Department I, Endocrinology and Diabetology, Bergmannsheil University Hospitals, Ruhr University of Bochum, Buerkle-de-la-Camp-Platz 1, D-44789 Bochum, Germany; Ruhr Center for Rare Diseases (CeSER), Ruhr University of Bochum and Witten/Herdecke University, Alexandrinenstr. 5, D-44791 Bochum, GermanyBackground: Subclinical hyperthyroidism/thyrotoxicosis originates from different causes and clinical conditions, sharing the laboratory constellation of a suppressed TSH in the presence of thyroid hormone concentrations within the reference range. Aim: Presentation of hyperthyroidism can manifest itself in several ways. We questioned whether there is either a consistent biochemical equivalence of thyroid hormone response to these diagnostic categories, or a high degree of heterogeneity may exist both within and between the different clinical manifestations. Methods: This secondary analysis of a former prospective cross-sectional trial involved 461 patients with untreated thyroid autonomy, Graves’ disease or on levothyroxine (LT4) after thyroidectomy for thyroid carcinoma. TSH response and biochemical equilibria between TSH and thyroid hormones were contrasted between endogenous hyperthyroidism and thyrotoxicosis (LT4 overdose). Results: Concentrations of FT4, FT3, TSH, deiodinase activity and BMI differed by diagnostic category. Over various TSH strata, FT4 concentrations were significantly higher in LT4-treated thyroid carcinoma patients, compared to the untreated diseases, though FT3 levels remained comparable. They were concentrated in the upper FT4- but low deiodinase range, distinguishing them from patients with thyroid autonomy and Graves’ disease. In exogenous thyrotoxicosis, TSH and FT3 were less responsive to FT4 concentrations approaching its upper normal/hyperthyroid range. Conclusions: The presence or lack of TSH feedforward activity determines the system response in the thyroid-active (hyperthyroidism) and no-thyroid response to treatment (thyrotoxicosis). This rules out a consistent thread of thyroid hormone response running through the different diagnostic categories. TSH measurements should therefore be interpreted conditionally and differently in subclinical hyperthyroidism and thyrotoxicosis. Keywords: Subclinical hyperthyroidism, Thyrotoxicosis, Deiodinasehttp://www.sciencedirect.com/science/article/pii/S2214623719301528
spellingShingle Rudolf Hoermann
John E.M. Midgley
Rolf Larisch
Johannes W. Dietrich
Heterogenous biochemical expression of hormone activity in subclinical/overt hyperthyroidism and exogenous thyrotoxicosis
Journal of Clinical & Translational Endocrinology
title Heterogenous biochemical expression of hormone activity in subclinical/overt hyperthyroidism and exogenous thyrotoxicosis
title_full Heterogenous biochemical expression of hormone activity in subclinical/overt hyperthyroidism and exogenous thyrotoxicosis
title_fullStr Heterogenous biochemical expression of hormone activity in subclinical/overt hyperthyroidism and exogenous thyrotoxicosis
title_full_unstemmed Heterogenous biochemical expression of hormone activity in subclinical/overt hyperthyroidism and exogenous thyrotoxicosis
title_short Heterogenous biochemical expression of hormone activity in subclinical/overt hyperthyroidism and exogenous thyrotoxicosis
title_sort heterogenous biochemical expression of hormone activity in subclinical overt hyperthyroidism and exogenous thyrotoxicosis
url http://www.sciencedirect.com/science/article/pii/S2214623719301528
work_keys_str_mv AT rudolfhoermann heterogenousbiochemicalexpressionofhormoneactivityinsubclinicaloverthyperthyroidismandexogenousthyrotoxicosis
AT johnemmidgley heterogenousbiochemicalexpressionofhormoneactivityinsubclinicaloverthyperthyroidismandexogenousthyrotoxicosis
AT rolflarisch heterogenousbiochemicalexpressionofhormoneactivityinsubclinicaloverthyperthyroidismandexogenousthyrotoxicosis
AT johanneswdietrich heterogenousbiochemicalexpressionofhormoneactivityinsubclinicaloverthyperthyroidismandexogenousthyrotoxicosis